IE870109L - Substituted peptide compounds - Google Patents
Substituted peptide compoundsInfo
- Publication number
- IE870109L IE870109L IE870109A IE10987A IE870109L IE 870109 L IE870109 L IE 870109L IE 870109 A IE870109 A IE 870109A IE 10987 A IE10987 A IE 10987A IE 870109 L IE870109 L IE 870109L
- Authority
- IE
- Ireland
- Prior art keywords
- oxo
- benzoylamino
- mmole
- lower alkyl
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 23
- 108090000765 processed proteins & peptides Proteins 0.000 title description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 46
- 229910052739 hydrogen Inorganic materials 0.000 claims description 39
- 239000001257 hydrogen Substances 0.000 claims description 39
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000001475 halogen functional group Chemical group 0.000 claims description 3
- 229910014033 C-OH Inorganic materials 0.000 claims description 2
- 229910014570 C—OH Inorganic materials 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 82
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 63
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 36
- -1 azido, amino Chemical group 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- 150000002431 hydrogen Chemical group 0.000 description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000002253 acid Substances 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 150000004702 methyl esters Chemical class 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 229960003767 alanine Drugs 0.000 description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 125000001309 chloro group Chemical group Cl* 0.000 description 7
- 125000001153 fluoro group Chemical group F* 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 229960002429 proline Drugs 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000001246 bromo group Chemical group Br* 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- ZJSQZQMVXKZAGW-UHFFFAOYSA-N 2H-benzotriazol-4-ol hydrate Chemical compound O.OC1=CC=CC2=C1N=NN2 ZJSQZQMVXKZAGW-UHFFFAOYSA-N 0.000 description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 4
- 229930194542 Keto Natural products 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 125000000468 ketone group Chemical group 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- LDECUSDQMXVUMP-UHFFFAOYSA-N benzyl 3-[6-[[2-(butylamino)-1-[3-methoxycarbonyl-4-(2-methoxy-2-oxoethoxy)phenyl]-2-oxoethyl]-hexylamino]-6-oxohexyl]-4-methyl-2-oxo-6-(4-phenylphenyl)-1,6-dihydropyrimidine-5-carboxylate Chemical compound O=C1NC(C=2C=CC(=CC=2)C=2C=CC=CC=2)C(C(=O)OCC=2C=CC=CC=2)=C(C)N1CCCCCC(=O)N(CCCCCC)C(C(=O)NCCCC)C1=CC=C(OCC(=O)OC)C(C(=O)OC)=C1 LDECUSDQMXVUMP-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 description 2
- OQMYZVWIXPPDDE-UHFFFAOYSA-N 2-(cyclohexylazaniumyl)acetate Chemical compound OC(=O)CNC1CCCCC1 OQMYZVWIXPPDDE-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229910052717 sulfur Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- UAGFTQCWTTYZKO-WCCKRBBISA-N (2s)-pyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H]1CCCN1 UAGFTQCWTTYZKO-WCCKRBBISA-N 0.000 description 1
- XRZWVSXEDRYQGC-ZJUUUORDSA-N (2s,4s)-4-cyclohexylpyrrolidin-1-ium-2-carboxylate Chemical compound C1N[C@H](C(=O)O)C[C@H]1C1CCCCC1 XRZWVSXEDRYQGC-ZJUUUORDSA-N 0.000 description 1
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000005978 1-naphthyloxy group Chemical group 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- ABGNZAIOJWGTTJ-UHFFFAOYSA-N 2-[(3-benzamido-2-oxo-4-phenylbutyl)-methylamino]acetic acid Chemical compound C=1C=CC=CC=1C(=O)NC(C(=O)CN(CC(O)=O)C)CC1=CC=CC=C1 ABGNZAIOJWGTTJ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000005979 2-naphthyloxy group Chemical group 0.000 description 1
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- YEWGIGCYIAMFMA-UHFFFAOYSA-N LSM-2007 Chemical compound C1C2=CC=CC=C2CCN(C)CCC2=C1NC1=CC=CC=C21 YEWGIGCYIAMFMA-UHFFFAOYSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 102000003729 Neprilysin Human genes 0.000 description 1
- 108090000028 Neprilysin Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000035389 Ring chromosome 6 syndrome Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 238000010266 Sephadex chromatography Methods 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- MMIQFBPFGNDAHA-UHFFFAOYSA-N benzyl n-(3-benzamido-2-oxo-4-phenylbutyl)-n-methylcarbamate Chemical compound C=1C=CC=CC=1COC(=O)N(C)CC(=O)C(NC(=O)C=1C=CC=CC=1)CC1=CC=CC=C1 MMIQFBPFGNDAHA-UHFFFAOYSA-N 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- PBMIETCUUSQZCG-UHFFFAOYSA-N n'-cyclohexylmethanediimine Chemical compound N=C=NC1CCCCC1 PBMIETCUUSQZCG-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- TZHVYFBSLOMRCU-YFKPBYRVSA-N tert-butyl (2s)-2-aminopropanoate Chemical compound C[C@H](N)C(=O)OC(C)(C)C TZHVYFBSLOMRCU-YFKPBYRVSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Substituted Peptide Compounds This invention is directed to compounds which may be useful in the preparation of substituted peptide compounds of formula 1 and salts thereof (I) O II R--CH-C- 3 I .
NH I C-O I R I O d ■CH-—s-CH — C-X CD X is an amino or Imino acid of the formula £ <*, 'ff- • \e r*» • V\ -N C-COOR -N—C-COOR ' _ l„v.a r. _ r, . low 10 R R v r* ' C*) » -N—C-COOR, -N—C-COOR, -N —C-COOK, ml) 6 i (&) 6 ml) 6 h a h or -H CH-COOR- I I R« *5 Rj is hydrogen, lower alkyl, halogen, fceto, O W / 19 hydroxy, -NH-C-lower alkyl, azido, amino, -H , *» ~£-p O -0 R1S ~ a 1- or 2-naphthyloxy of the formula -0- , -S-lower alkyl. 14}p -S- Qj_ or a 1- or 2-naphthylthio '"l3'p -4- 15 20 of the formula -S-(CH2)m, 0 H R_ is keto, halogen, | / 15 " -0-C-N ' ***""*15 10 -O-(CHj)/ -O-lower alkyl, a 1- or -S-lower alkyl, -S-(CH2J^-/qN V—^CRl3»p or a 1- or 2-naphthylthio of the formula fOTOj- i*14»p 25 is keto or - (CHj) 13 p -5 10 15 20 R10 is halogen or -Y-R16. *ll' *11 ' *12 *nd R'l2 are independently selected from hydrogen and lower alkyl or R'j^ r12 and R'12 are hydrogen and R^ is R13 is hydrogen, lower alkyl" of 1 to 4 carbons, lower alkoxy of .1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluororaethyl, hydroxy, phenyl, phenoxy, phenylthio, or phenylmethyl. ^ is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy. m is zero, one, two, three, or four. p is one, two-or three provided that p is more than one only if R^3 or Rj^ is hydrogen, methyl, methoxy, chloro, or fluoro.
R^s is hydrogen or lower alkyl of 1 to 4 carbons.
T is oxygen or sulfur. *16 ia lower alkyl of 1 to 4 carbons. <*13>p , or the H^g groups join to 30 complete an unsubstituted 5- or 6-membered-ring -6- 10 15 20 25 or said ring in which one or more of the carbons has a lower alkyl of 1 to 4 carbons or a di(lower alkyl of 1 to 4 carbons) substituent.
R, is hydrogen, lower alkyl, .—.
-(CH2'iT© -(CH^-cycloalkyl, , -(C^),^ .
-«CH2>ir{0) - *
B H -(CH2)r-SH, -(CH2)r-s-lower alkyl, -(CH^-NH-C , or -(CH2)r-C—NHj 30 VNH2. -7- r is an integer from 1 to 4.
R19 is lower alkyl, benzyl, or phenethyl. R20 is-hydrogen, lower alkyl, benzyl or phenethyl.
R is hydrogen, lower alkyl, cycloalkyl, ' -tCH2)2-MH2, -(CH2)3-HH2 , -(ch2)4-nh2, -(ch2)2-oh, -(ch2)3-oh, -Cch2)4-oh, -(ch2)2-sh, -cch2)3-sh, or -{ch2)4-sh.
R^ is hydrogen, lower'alkyl,-halo substituted 15 lower alkyl, /-~K /—\ -(CB2,£-© ' 10 20 -(ch2)f^-°h ' "tCH2>rl~3@ oh | h ■(ch2)y i| n / *(chj), "(chj)^~sh| 25 I B -(CHj)r-OH, -(CB2)r-s-lower alkyl, O MB | 30 -CCB2)r-NB-C-^' , or -(CB2Jr-C-HB2 NHj -H- 10 IS 25 provide^ th#t R^ is' hydrogen only if R is other than hydrogen..
R2 is -«c"a,r®>IR , ' -•"j'.-O 14 p s -(ch2>5KE^3 'or -'"Vi-fQ) • R3 is hydrogen, lower alkyl, '"m'p "^s-* , halo substituted .20 lower alkyl, -(CH,)m-cycloalkyl, -1CH,)^^-0H , OH (CH2)?inS) ' -JCH2)r-OH, . 30 -9- -lCH2)r-HH2, -(CH2)r-SH, -(CH2)r-S-lowcr alkyl, mu o "
Kg is hydrogen, lower alkyl, benzyl, benzhydryl, J , ?21 {? 10 -ch-o-c-r, „ -c c-o-r i 18 , 23 1*17 *22 IS -CH-(CH-OH) _ , or -CH-CH—CH 2 ■ I I ob ob R^ is hydrogen, lower alkyl, cycloalkyl, or phenyl.
R ' is hydrogen, lower alkyl, lower alkoxy, or phenyl or RJ7 and Rjg taken together are -(CH2>2-, 20 -(ch2)3-, -ch-ch- - 25 R2^ and Rjj are independently selected from hydrogen and lower alkyl.
Rjj is lower alkyl. - 10 - In accordance vith the invention, there is prQvided a compound of the foraula (II) O O R R O ii I in R--C-NH-CH-C-CH--N - CH-C-OH • I »3 wherein: R is hydrogen, Prot, lower alkyl, cycloalkyl, ' -(.CH2)2-8-Prot , -(CH2)3-3-Prot, -jch2)4-S-Prot, -|ch2)J-Q-Prot, -(chj)j-O-Prot, -(CH2)4-0-Prot , -(C»2)2-S-Prot, -(CHj)j-S-Prot, or -(CHj)^-S-Prot; ' R^ is hydrogen, lower alkyl, halo substituted lower alkyl, f -(CH^p^^b-Prot, (CH2)r@-°-prot' -(cVrirn[ol O-Prot N (CHj), -(CH2)r-S-P.rot -, -(CM2)r-S-lower alkyl I Prot ™ H Ar (CH2)r-0-Prot, -(CH2)r-N-Prot, - ^ Nll-Prot - 11 10 o II or -(CH2>r-C-NH2 provided that R^ is hydrogen only when R is other than hydrogen; Prot is an easily removable protecting group; R2 is >s®\, , 14 p ,ir"@ R3 is hydrogen, lower alkyl, -(ch2)^-/qN , <*4>P • ■|ch2,S~5~3 s (CH2), ;—pOl » halo substituted lower alkyl.
- (CH2) ^-eycloalkyl, - (CH2) qh , OH - 12 - - (CH2} r fi l'ol ' _lCH2)r"OH' I H -(CH,) 2)f-lj jft , -(CH2)r-NH2, -(CH2)r-SH, -(CHj) r~S-lower alkyl, O -{CH2)r-C-NH2 1 j 5 R14 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy; m is zero, one, two, three, or four; 10 p is one, two or three provided that p is more than one only if is hydrogen, methyl, methoxy, chloro, or fluoro; and z is an ■ integer from 1 to 4'.
-(CH.) -NH-C « r « ,NH NH„ 13 The tern lower alkyl used in defining various symbols refers to straight or branched chain radicals having up to seven carbons. The preferred lower alkyl groups are up to four carbons 5 with methyl and ethyl most preferred. Similarly the terms lower alkoxy and lower alkylthio ° refer to such lower alkyl groups attached to an oxygen or sulfur.
The term cycloalkyl refers to saturated 10 rings of 3 to 7 carbon atoms with cyclopentyl and cyclohexyl being most preferred.
The term halogen refers to chloro, bromo and fluoro.
The term halo substituted lower alkyl refers IS to such lower alkyl groups described above in which one or more hydrogens have been replaced by chloro, bromo or fluoro groups such as trifluoromethyl, which is preferred, penta-fluoroethyl, 2,2,2-trichloroethyl, chloromethyl, 2C bromomethyl, etc.
The symbols -(CHj^ , -(CH^ and "(CH2'm"|OJ bridge is attached to represent that the alkylene an available carbon atom. - 14 - The compounds of formula I may be prepared by coupling a compound of the invention with the amino or imino acid ester of the formula (HI) 5 HX in the presence of a coupling agent such as dicyclo-hexylcarbodiimide wherein in the definition of X is an easily removable protecting group.
Removal of the Rfi protecting group yields the 10 products of fonnula X wherein Rg is hydrogen.
A compound of the invention can be prepared by reacting an aminofcetone of formula (IV) O 0 ? II 1 1 R -C-NH-CH-C-CH2-NH 2 I 15 with a haloacetic acid ester of the formula (V) *1 ° r « halo-CH— C-O-Prot (X.) wherein Prot is an easily removable ester protecting group such as t-butyl to yield the ester (VI) o o r r, o p i I i1 r r -c-nh-ch-c-ch -nh- ch - C-O-Prot I *3
A compound of the formula (IV) can converting the carboxyalkylamine of the formula (VII) r I ho-c-ch2-h-r40 p o wherein R^g is a protecting group such as benzyloxy-carbonyl, to its acid chloride and then reacting with an oxazolone of formula (VIII) to yield (IX) O II r2-c-nh compound of the be prepared by I I -ch-c-ch2-n-r40 - 16 - Removal of the R^g protecting group such as by hydrogcnation yields the reactant of foraula (IV).
The aminoketone of foraula (IV) wherein R is other than hydrogen can also be prepared by reacting the ketone of formula (X) O O II I "V R2-C-NH-CH-C-CH,-halo I *3 wherein halo is CI or Br with a substituted amine of the foraula (XI) R-NHj Compounds of formula (X) and their preparation are described and 10 claimed in our Patent Application No. ( ).
In the above reactions if any or all of R, Rj , Rj and are -(CH2 OB -(CH2)r-N82. -«Vrir"f| ' -CCH2)r-SH, I B ^N" 15 -(CBj)r~OB, 2 - J7 - then the hydroxyl, amino, imidazolyl, mercaptan or guanidinyl function should be protected during- the reaction. Suitable protecting groups include benzyloxycarbonyl,. t-but'oxycarbonyl, benzyl, benzhydryl, trityl, etc., and nitro in the case of guanidinyl. The protecting group is removed by hydrogenation, treatment with acid, or other known methods following completion of the reaction.
Preferred compounds of this Invention with respect to the peptide part of the structure are those.wherein: R is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or phenyl.
R^ is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, -CFj, -(CH2)r-NH2 wherein r is an integer from 1 to 4, ' -B^OR OB "CH2X3@ ' "CH2T^jf ' ~CVSH' -NH -(cb2)2-s-ch3, "(chjjjnhc^ , -chj-oh, nb2 O O II I -CHj-C-NHj, or -(CHjlj-C-NBj provided that R^ 2.) is hydrogen only if S is other than hydrogen.
Most preferred compounds of this invention with respect to the peptide part of the structure are those wherein: R is hydrogen or methyl.
R^ is hydrogen, methyl, or 25 especially methyl, provided that R^ is hydrogen only if R is other than hydrogen. - 18 - Preferred compounds of this invention with respect to the keto portion of the structure are chose wherein: R2 is ■ -B^©L . « *14 M wherein a is" zero, .one,- or two, R^ is' hydrogen .methyl, methoxy, methylthio, CX, Br, F, or hydroxy, and r is an integer from 1 to 4, especially benzyl.
An asynnetric center is present in the keto portion of 15 the compounds of the invention vhen R^ is other than hydrogen. Thus, the compounds can exist in diastereolsomeric forms or in mixtures thereof. The above described processes can utilize racemates, enantiomers or diastereomers as 20 starting materials. ' When diastereomeric products are prepared, they can be separated by conventional chromatographic or fractional crystallization methods.
The compounds of formula X, and the pharma-25 ceutically acceptable salts thereof, are hypotensive agents. - 19 - The compounds of formula X wherein X is -NH-CH-COOR also possess enkephalinase I 6 *5 inhibition activity and are useful as analgesic agents. 5 Compounds of formula (I), as well as pharmaceutical compositions containing them and additional processes for their preparation, are further described and claimed in parent Patent Application No. >655/83.
The following examples are illustrative of the 10 preparation of compounds of the invention, as well as their use in the preparation of compounds of formula (I). Temperatures are given in degrees centigrade. LH-20 refers to a Sephadex chromatography gel commercially available from Pharmacia Fine Chemicals. - 20 - Example I N-[N-t3-(Benzoylamlno)-2-oxo-4-phenylbutvl1-N-i:iethvl-glycyll -N-cyclohexylglyclne, mononydrochloride a) 13- (Benzoyl amino) -*2-oxo-4-phenylbutyllmcthyl-carbamlc acid, phenylmethyl ester N-methyl-N- [ (phenylmethoxy) carbony1] glycine (2.23 g., 10 mmole) is dissolved in 30 ml. of tetrahydrofuran and cooled in an ice-bath. Oxalyl chloride (1- nil., 11.5 mmole) is added followed by 2 drops of dimethylformamide. After stirring for 30 minutes in' the ice-bath, the mixture is then stirred at room temperature .for an hour. To this 0.25 ml. of oxalyl chloride is added. The mixture is evaporated, redissolved in 15 ml. of tetrahydrofuran, and stirred in an ice bath. A solution of 2-pl»enyl-4-(phenylmethyl)-5(4H)-oxazolone (3.1 g., 12.4 mmole) dissolved in 15 ml. of tetrahydrofuran is added to the above solution stirring in the ice-bath. Triethylamine' (1.4 ml., 10 mmole) is added and the solution is stirred at room temperature overnight. The precipitated triethylamine hydrochloride salt is' filtered off. Tetrahydrofuran is removed from the residue and it is then redissolved in pyridine (5 ml.) and p-dimethylamino pyridine (20 mg.) is added. After stirring at room temperature for 3 hours, acetic acid (5 ml.) is added and the.reaction mixture is kept at 105" for 30 minutes. The reaction mixture is.then evaporated, the residue is dissolved in ethyl acetate, and washed with aqueous sodium bicarbonate and water. After trituration with ethyl acetate/ hexane, 2.2 g. of homogeneous [3-(benzoylamino)-2-oxo-4-phenylbutyl]methylcarbamic acid, phenylmethyl ester is obtained; m.p. 140-141*. - 21 - b) (1)-N-13-(Methvlamino)-2-oxo-l-(pheny liaethyl) -propyl Ibenzamidei' hydrochloride {3- (Benzoylamino) -2-oxo- 4-pheny lbuty 1 ] me thy 1-carbamic acid, phenylmethyl ester (0.5 g.) is 5 dissolved in ethanol (50 ml.) containing IS hydrochloric acid (2 ml.). Palladium carbon catalyst (lOt, 100 mg.) is added and hydrogenation is continued overnight. The reaction.mixture is then filtered, evaporated, dissolved in water, 10 and lyophilized to 300 mg. of (±)-N-[3-(methyl-amino)-2-oxo-l-(phenylmethyl)propylJbenzamide, hydrochloride as a homogeneous white powder. c) ft) -M- [3- (Benzoylamino) -2-oxo-4-phenylbutyll-N-methylqlycine,1,1-dimethylethyl ester 15 To a solution of (±) -N-[3- (methy laraino)-2-. oxo-1-(phenylmethyl)propyl]benzamide (5.0 g., 15 mmole) , prepared as set forth in (b) above, in dimethylformamide (20 ml.) is added bromoaeetlc acid, 1,1-dimethylethyl ester (13.8 g., 3.15 ml., 20 19.5 mmole) and diisopropylethylamine (2.5 g., 3.4 ml., 19.5 mmole). After 'stirring overnight at room temperature, the.reaction mixture is poured into water (100 ml.) and extracted with ethyl acetate (3x). The combined ethyl acetate 25 extracts are washed with saturated sodium bicarbonate (twice), 10% potassium bis'ulfate (twice)', and water (twice), dried' (Ha^SO^), and concentrated into a yellow oil, .which bccomas * dried up foam upon drying in high vacuum, to give 5.4 g. of 30 (t)-N-13-(benzoylamino)-2-oxo-4-phenylbutyl ] -N-methylglycine, 1,1-dimethylethyl ester. - 22 - d) (D-N-C3-(Benzoylamino)-2-oxo-4-phcnylbutyll-M-methylglycine. monohydrochlorlde The ester produdt from pact (c) (4.51 g., 11 mmole) is treated with 2N hydrochloric acid/ 5 acetic acid (20 ml.). After stirring for 2.5 hours at room temperature, the reaction mixture is concentrated uiider rcduced pressure and the oily residue is triturated with ether to give 3.3 g. of (±) -N- (3- (benzoylamino) -2-oxo-4-phenylbutylJ-10 N-methylglycine, monohydrpchloride as an off-white solid. el M-Cyclohexylqlycine,' 1.l'-dimethylethyl ester Cyclohexylamine (70.35 ml.) and sodium bicarbonate (12.9 g.) are suspended with stirring IS in 200 ml. of absolute ethanol while stirring in an ice-bath. To this is' added bromoacetic acid, 1,1-dimethylethyl ester (20.78 ml.) dropwise. The ice-bath is removed. After 24 hours at room temperature, the reaction mixture is concentrated 20 to dryness, taken into chloroform and washed with water. The crude product (42 g.) is chromato-graphed on silica gel eluting with ethyl acetate: hexane (2:1) to give 27.4 g. of N-cyclohexyl-glycine, 1,1-dimethylethyl ester. 25 f) W- [N- f 3- (Benzoylamino) -2-oxo-4-phenylbutyl)-H- methylqlycyll -N-cyclohexylglycine. 1,1-dimcthylethyl ester To a solution of (i)-N-l 3-(benzoylamino) -2-oxo-4-phenylbutyl] -N-methylglycine, hydrochloride 30 (1.0 g., 2.6 mmole) in distilled tetrahydrofuran (50 ml.) is added'N-cyclohexylglycine, 1,1-dimethylethyl ester (0.55 g., 2.6 mmole), prepared as set forth in (e) above, hydroxybenzotriazole hydrate (0.39 g., 2.6 mmole),arid dicyclohexyl-35 carbodiimide (0.S5 g., 2.6 mmole). The reaction mixture is stirred overnight, the precipitated - 23 - dicyclohexylurea is filtered off, and the filtrate is concentrated. The residue is dissolved in ethyl acetate (SO ml.) and washed with saturated sodium bicarbonate (twice), lot potassium bisulfate 5 (twice), and water (twice), dried (Na^SO^) and concentrated into an oily residue (1.5 g.). Flash chromatography (100 g., Merck silica gel 60) gives 0.49 g. of N-(N-[3-(benzoylamino)-2-oxo-4-phenyl-butyl) -N-methylglycyl] -R-cyclohexylglyclne ,1,1-10 dimethylethyl ester as a foam. a) N-'[N-t3- (Benzoylamino) -2-oxo-4-phenylbutvl)-N-methylqlycyl)-N-cyclohexylglyclne, monohydrochlorlde The ester product from part (f) (0.48 g., 0.87 15 mmole) is treated with 2N hydrochloric acid/acetic acid (10 ml.). After stirring for 2 hours at room temperature, the reaction mixture is concentrated under reduced pressure and the oily residue is triturated with ether pvernight to give 0.32 g. 20 of N-[H-13- (benzoylamino) -2-oxo-4-phenylbutylJ-N-methylglycyl]-N-cyclohexylglycine, monohydrochlorlde as an off-white solid; m.p. 131-145°. Kg 0.36 (silica gel, n-butanol/acetic acid/water> 4:1:1). 25 Anal, calc'd. for C28H35H3°5 " I*C1' * °-7 H^O: C, 61.95; R, 6.95; N, 7.74; CI, 6.53 Found: C, 61.95; H, 6.74; N, 7.71; CI, 6.23.
. Example 2 IS1 —7— 11 [ (±)-3-(Benzoylamino) -2-oxo-4~phcnylbutyl)-' methylamlnolacetyl) -1.4-dithia-7-azaspiro[4.4)-nonane-8-carboxyllc acid, methyl ester To a solution of (±)-N-[3-(behzoylamino)-2-oxo-4-phenylbutyl] -N-methylglycine, monohydrochloride (1.0 9.-, 2.5 mmole), prepared as set. forth in Example 1(d), in distilled tetrahydrofuran (SO ml.) ia added (S)-l,4-dithia-7-azaspiro(4.4]nonane-8-« carboxylic acid, methyl ester, monohydrochloride (0.66 g., 2.S mmole), dicyclohexylcarbodiimide (0.54 g., 2.5 mmole), hydroxybenzotriazole hydrate (0.39 9., 2.5 'mmole) and diisopropylethylam'ine (0.9 ml., 5- mmole). The reaction mixture is stirred overnight, the precipitated dicyclohexylurea is filtered off, and the filtrate is concentrated. The residue is dissolved in ethyl acetate (100 ml.) and washed with saturated sodium bicarbonate (twice) and water (twice), dried (N«2SO^), and concentrated into a yellow oily residue (1.3 g.). Flash chromatography- (Merck silica gel, 251 ethyl acetate/methylene chloride. It methanol/methylene chloride) affords 0.53 9. of (S)-7-((I(±1-3-(benzoylamino) -2-oxo-4-phenylbutyl]methylaaino]-acetyll -1, 4-dithia-7.-azaspirof 4 .4]nonane-8-carboxylie acid, methyl ester as a white foam; m.p. 60 -r 62". 0.52' (silica gel, 51 methanol/ methylene chloride).
Axial, calc'd. for c2bH33N3°5S2 * 0,33 H2°* - 25 - C, 59.87; H, 6.04; N, 7.48; S, 11.42 found: C, 59.87; H, 5.94; N, 7.56; S, 11.36.
Example 3 (S) —7— f 11 (1) -3- (Benzoylamino) -2-oxo-4-phenvlbutyll-5 methylamino] acetyl] -1.4-dithla-7-a»asplrot 4.41 nonane-8-carboxyllc acid, methyl ester, monohydrochloride The methyl ester product from Example 2 (0.26 g., 0.46 mmole) is treated with 2N hydrochloric acid/acetic acid until homogeneous 10 (2 minutes), concentrated under reduced pressure, and the oily residue is triturated with ether (twice) to give 0.26 g. of (S)-7-II((i}-3-(benzoylamino) -2-oxo-4-p.henylbutyl]methylamino) -acetyl] -l,4-dithia-7-azaspiro[4.4 ] nonane-8-15 carboxylic acid, methyl ester, monohydrochloride as a white solid; m.p. 79-85". R^ 0.53 (silica gel, 5t methanol/methylene chloride).
Anal, calc'd. for C28H33N3°5S2 * HC* * 0.56 H^O: C, 55.84; R, 5.88; N, 6.98; S, 10.64; Cl,5.88 20 Found: C, 55.84; H, 5.95; N, 6.78; S, 10.43; Cl.5.66.
Example 4 (4S) -1- rw-f3- (Benzoylamino) -2-oxo-4-phenylbutyl 1 -N-methvlqlvcvll-4-(4-fluoroohenoxy)-I.-orollng. methyl ester, monohydrochloride 25 a) C 4S) -4- Ifluorophanoxy) -L-proIine. methyl ester.' monohydrochloride TO a suspension of (4S)-4-(fluorophenoxy)-L-proline (2.5 'g., 11 mmole) in methanol at -3.0* under an argon atmosphere is' added thionyl 30 chloride' (8.09 ■!., 11 mmole). The reaction mixture / ■ - - 26 is stirred at -20" for 2 hours, then at room temperature for 16 hours. Solvent is removed at reduced pressure and the 'residue is redissolved in methylene chloride (ISO ml.) and washed with' IN sodium carbonate (twice) and water (twice).
After drying (MgSOj), excess hydrochloric acid/ methanol is added and solvent is removed at reduced pressure. Addition of ether gives a light brown solid (2.6 g.). Recrystallization from methanol/ ether gives 1.49 g. of (4S)-4.-(.fluorophenoxy)-L- proline, methyl ester, monohydrochloride as a 20 light brown solid; m.p. 147-148"; (a]Q » +6.96" (c ■ 1.5S, methanol). b) (4S)-l-[N-[3- (Benzoylamino) -2-oxo-4-phenylbutyl'] -N-methylqlycyl] -4- (4-f luorophenoxy) -L-proline. methyl ester To a solution of (±)-N-[3-(benzoylamino)-2-oxo-4-phenylbutyl] -N-methylglycine, monohydrochloride (1.17 g., 3 mmole), prepared as set forth in Example 1(d), in distilled tetrahydrofuran (20 ml.) is added (4S)-4-(fluorophenoxy)-L-proline, methyl ester, monohydrochloride (0.82 g., 3 mmole), hydroxybenzotriazole hydrate (0.46 g., 3 mmole) and di'cyclohexylcarbodiimide (0.62 g., 3 mmole). The reaction mixture is stirred overnight, the' precipitated dicyclohexylurea is filtered off, and the 'filtrate is concentrated. The residue is dis'solved in ethyl acetate (50 ml.) and washed with saturated sodium bicarbonate (twice) and water (twice) , dried (Na^SO^) ,' and concentrated into an - 27 - oily residue (l.lg.). Flash chromatography (200 g.f Herck silica gel 60} 3% methanol/chloroforra) gives 0.1S g. of (4S)-1-III-13-(benzoylamino)-2-oxo-4-phenylbutyl] -N-mcthylglycyl J-4-(4-f luoro-S phenoxy)-L-proline, methyl ester as a foam. c) (4 S)-1-tN-13- (Benzoylamino) -2-oxo-4-phenvl-butvll -N-methylqlvcyl)-4- (4-fluorophenoxv) -2-prollne. methyl ester, monohydrochloride The methyl ester product from part (b) 10 (0.15 g., 0.26 mmole) is treated with 2N hydrochloric acid/acetic acid until homogeneous (2 minutes), concentrated under reduced pressure, and the oily residue is triturated with ether (twice) to afford 0.14 g. of (4S)-l-[N-[3-15 (benzoylamino)-2-oxo-4-phenylbutylI-N-methyl-glycyl ] - 4- (.4-fluorophenoxy) -L-proline, methyl ester, monohydrochloride as an off-white solid; m.p. 105-125". R^ 0.27 (silica gel, 5% methanol/ chloroform). 20 Anal, cale'd. for • HCl C, 62.79; B, 5.76; M, 6.86; F, 3.10; Cl,5.79 Found: C, 62.78; R, 5.73; N, 6.87; F, 2.83; Cl,5.33.
■Example 5 MS)-1-INtIS)-3-(Benzoylamino)-2-oxo-4-phcnylbutyll-L-alanyll-4-(4-fluorophenoxy)-L-prollne, monohydrochloride a) (S)-N-[3-(Benzoylamino)-2-oxo-4-phenylbutyl1-L-alanine, 1.1-dimethylethyl ester To a stirring solution of (S)-H-[3-chloro-2-oxo-l-(phenylsiethyl)propyl]benzamide (10.0 g., 33.1 mmole) in dimethylformamide (80 ml.) is added L-alanine, 1,1-dimethylethyl ester, hydrochloride (6.0 g., 33.1 mmole), sodium bicarbonate (6.1 g., 72 molt) and sodium iodide (4.9 g., 33.1 mmole). The resulting solution is stirred overnight at room temperature, poured into ether and washed with water (twice) and 10% sodium bicarbonate. The ether solution is extracted with IN hydrochloric acid (3x), the combined extracts are made basic by the addition of solid sodium' bicarbonate and extracted with ethyl acetate (4x). The organic extracts are combined, dried (HgSO^) and concentrated to give 8.9 g. of pal* yellow solid. A portion of this material is recrystallixed from ethyl acetate to give (S)-N-(3-(benzoylamino) -2-oxo-4-phenylbuty 1J -L-alanine, 1,1-dimethylethyl ester as a white solid; m.p. 106.5 - 110". - 29 - b) (S)-H- [3- (Bcrizoylaiftlno)-2-oxo-4-phcnylbutyl)-L-alanine, monohydrochloride A solution of the ester product from partes) (2.95 g., 5.4 mmole) in 1.4 N hydrochloric acid in 5 acetic acid- (39 ml.) is stirred at roon temperature for 2 hours. The resulting white precipitate is collected, rinsed with ether and dried to give 2.27 g. of (S)-N-f3-(benzoylamino)-2-oxo-4.-phenylbutyl]-L-alanine, monohydrochloride; 10 m.p. 208-209* (dec.); [o]D = -7,1* (c - 0.38% in methanol). 0.51 (silica gel; chloroform/-methanol/acetic fccid; 4:1:1).' Anal, calc'd. for C20H22N2°4 * HC^S C, 61.64; H, 5.93;. N, 7.17; CI, 9.07 15 Found: C, *1.33; H, 5.97; K, 7.17; CI, 8.79. c) " (S) -M- [S- (Benzoylamino)-2-oxo-4-tShghvlbutylI -W- T (pheny Imethoxy) carbonyl | -L-alanine Triethylamine (2.1 ml., 15 mmole)' is added to a mixture of (S) -N-(.3- (benroylamino)-20 2-qxo-4-phenylbutyl]-L-a.lanine, monohydrochloride (2.0 g., 5.1 mmole), benzyl chlorofpzmate (730 jil., . 5.1 mmole)water' (7 ml .J and dioxane' (7 ml.) at 25*. The resulting mixture is stirred at 25* for 3 hours, after which it' is' poured into 25 5% aqueous- sodium bicarbonate solution and ' washed with ether. The aqueous layer is' acidified (HCl)and extracted.into ethyl acetate (3x). The extract is' dried' (MgSO^) and concentrated to give a colorless oil*. ' Trituration with ether ' 30 produces a white granular solid '(150 'mg.! which - 30 - is collected and discarded. The mother liquor is concentrated in vacuo to give 1.7.5 g. of (S)-N-[N-(benzoylamino)-2-oxo-4-phenylbutyl]-N-((phenylmethoxy) carbonyl] -L-alanine as a white glass. d) (4S)-l-[N-t(S)-3-(Benzoylamino)-2-oxo-4-phenylbutvll -N- [ (phenylmethoxy) carbonyl 1 -L-alanyll-4-(4-fluorophenoxy)-L-proline. phenylmethyl ester A mixture of (S)-N-I.N-(benzoylamino)-2-oxo-4-phenylbutyl]-N- ('(pheny lmethoxy)carbonyl]-L^ alanine (300 mg., 0.62 mmole), (4S)-4-(4-fluorophenoxy) -L-p.roline, phenylmethyl ester, p-toluenesulfonic acid salt (300 mg., 0.62 mmole), triethylamine (90 yl., 0.62 mmole), dicyclo-hexylcarbodiimide (130 mg., 0.62 mmole), and hydroxybenzotriazole hydrate (90 mg., 0.62 mmole) in tetrahydrofuran (7 ml.) is stirred at 25* £or 20 hours. The mixture is then filtered and diluted with ethyl acetate. The resulting solution is washed sequentially with IN hydrochloric acid and 10% aqueous sodium bicarbonate solution, dried (MgSO^), filtered, and concentrated to give 500 mg. of (4S)-l-(N-[(S)-3-(benzoylamino)-2-oxo-4-phenylbutyl] -N- [ (phenylmethoxy) carbonyl] -L-alanyl] -4- (4-fluorophenoxy) -L-proline, phenylmethyl ester as a pale yellow oil. - 31 - e) (.4S)-l-m-'[ (S)-3-(Benzoylamino)-2-oxo-4-phcnylbutyl)-L-alanyll-4-(4-fluorophenoxy)-L-prollne. monohydrochloride A mixture of the ester product from part(d) 5 (500 mg., 0.6 mmole), palladium on carbon catalyst (10%, 100 mg.), absolute ethanol (15 ml.), and 1.0 N aqueous hydrochloric acid (800 yl., 0.8 mmole) is hydrogenated at 1 atmosphere and 25* for 17 hours, after which it is filtered and concentrated. 10 The residue is chromatographed on HP-20 a linear gradient from (9:1, 0.01N aqueous hydrochloric acid:methanol] tp [1:1, 0.01N aqueous hydrochloric acid:methanol]. Fractions containing the desired product (TLC) are combined and concentrated. The 15 residue is dissolved in a minimum amount of methanol. Ether.is added, resulting in a white precipitate which is collected and dried in vacuo to give 200 mg. of (4S) -1- [N-[ (S) -3- (benzoylamino) -2-oxo-4-phenylbutyl] -L-alanyl]-4- (4-f luorophenoxy) -20 L-proline, monohydrochloride; m.p. 152-153° (dec.); [alj® ■ -50s (c » 0.5, methanol). Rg 0.75 (silica gel, chloroforra/methanol/acetic acid, 4:1:1).
Anal, calc'd. for C3iH32FN3°£ * ^ * 1-5 HjO: 25 C, 59.57; H, 5.80; N, 6.72; CI', 5.67 Found: C, 59.68; H, 5.56; N, 6.67; CI, 5.99. - 32 -Example 6 [1 (S) .-4R1-1- [N-[3- (Benzoylamino) -2-oxo-4-phenvlbutvll-L-alanyll-4-phenyl-L-prollne. monohydrochloride aj (Si-N-[N-(Benzoylamino)-2-oxo-4-phenvlbutylj -N- 5 f (phenylmethoxy).carbonyl)-L-alanlnc. succinimido ester A mixture of (S)-N-[N-(benzoylamino)-2-oxo-4-phenylbutyl]-N-((phenylmethoxy)carbonyl]-L-alanine .(800 mg., 1.6 mmole), prepared as set forth In Example 5 (c), dicyclohexylcarbodiimi.de 10 (340 mg., 1.6 mmole), and N-hydroxysuccinimide (190 mg., 1.6 mmole) in tetrahydrofuran (5 ml.) is stirred at 25? for 18 hours. After this tiiae it is filtered and concentrated'to give 950 mg. of (S)-N-(N-(benzoylamino)-2-oxo-4-phenylbutyl]-15 H- [(phenylmethoxy)carbonyl]-L-alanine, succinimido ester. b) fl(S).4R]-l-rN-f3-(Benzoylamino)-2-oxo-4-phenylbutyll-N-t(phenylmethoxy)carbonyl]-L-alanyl]-4-phenyl-L-prollne 20 To a solution of (S)-N-[N-(benzoylamino)-2- oxo-4-phenylbutyl]-N-((phenylmethoxy)carbonyl]-L-alanine, succinimido ester (950 mg., 1.6 nuaole) in dimethylformamide (5 ml.) is added (4R)-4-phcnyl-L-proline, hydrochloride (375 mg., 1.7 mmole) 25 and triethylamine (40 pi., 3.2 mmole). The resulting mixture is .stirred at 25* for 24 hours, after which it is poured into excess.IN hydrochloric acid and extracted with ethyl acetate (3x). The extracts are combined, dried (MgSOj), 30 filtered, and concentrated to give 1.1 g. of IX (S) , 4RJ—1—IN-[3-(benzoylamino)-2-oxo-4-phenyl-butyl] -N-[(phenylmethoxy)carbonyl]-L-alanyl]-4-phenyl-L-proline. e) H(S).4RJ-1-IN-I3-(Benzoylamino)-2-oxo-4-phenvlbutvl]-L-alanvl]-4-phenyl-L-proline. mono- . hydrochloride The product from part (b) (1.0 g., 1.5 mmole), ethanol (20 ml.)* water (5 ml.), 1.0 N hydrochloric acid (1.5 ml., 1.5 mmole), and palladium on carbon catalyst (10%, 100 mg.) is hydrogenated at one atmosphere and 25s for 18 hours, after which it is filtered and concentrated. The residue is chromato-graphed on HP-20 -using a linear gradient (0.01 N aqueous hydrochloric acid:methanol, 40:60 to 10:90]. Fractions containing the desired product (TLC) are combined and concentrated. The residue is dissolved in .a minimum amount of methanol. Ether is added and the resulting white precipitate is collected and dried to give 300 mg. of [ 1 (S) ,4R]-1-IN-(3- (benzoylamino) -2-oxo-4-phenyl-butyl]-L-alanyl}-4-phenyl-L-prollne, monohydrochloride; m.p. 160-162* (dec.); la]** - -57* (c « 1.5., methanol). Rg 0.8 (silica gel; chloroform/methanol/acetic acid; 4:1x1).
Anal, calc'd. for C3lH33 N3<>5 • HC1 - 1.35 HjO: C, 63.27; H, 6.29; N, 7.14; CI, 6.02* Found: C, 63.27; R, 6.17; N, 7.19; CI, 5.97.
Example 7.
III5I . 4S1-1-[N-[3-(Benzoylamino)-2-oxo-4-pheny1-butyll-L-alanyll-4-phenyl-L-proline. monohydrochlorlde Following the procedure of Example 6 but employing (4S)-4-phenyl-L-prolinej hydrochloride in part (b), one obtains (1(S),4S]-l-[N-j3-(benzoyl-amino) -2-oxo-4-phenylbutyll-L-alanyl-4-phenyl-L-proline, monohydrochloride; m.p. 138-143*; (aJD ■ -61* (c ■ 0.34 in methanol). R^ 0.84 (silica gel, chloroform/methanol/acetic acid, 4:1:1).
Anal, calc'd. fpr C31H33N305 • HC1 • 2-13 HjO: C, .61.80; B, 6.3S; S, 6.98; CI, 5.88 Found: C, 61.80; H, 6.06; ft, 7.05; Cl, 5.65.
Example 8 tl(S) ,4Rl-I-tN-t 3- (Benzoylamino) - 2-oxo-4-pheny 1-butyll -L-alanyll-4-cvclohexyl-L-prollne. monohydrochloride Following the procedure of Example 6 but employing (4K)-4-cyclohexyl-L-proline, hydrochloride in part (b) , one obtain* (1(S),4R]-1-[N-[3- (benzdylaminb-2-oxo-4-phenylbutyl] -L-alanyl] -4-cyclohexyl-L-proline, monohydrochloride; m.p. 140-154* (dec.); [o]D » -83* (c - 0.36% in methanol). R^ 0.84 (silica gel; chloroform/ methanol/acetic acid; 4:1:1). - :js - Anal., calc'd. for CjjHjjNjOj • HC1 - 0.79 HjO: C, 63.71; H, 7.17; N, 7.19; Cl, 6.06 Found: C, 63.71; H, 7.21; N, 7.05; Cl, 5.82.
Example 9 5 (1(S).4 S1-1-[M-[3-(Benzoylamino)-2-oxo-4-phenyl-•butyll-L-alanyll-4-cyclohexyl-L-proline. monohydrochloride Following the procedure of Example 6 but employing (4S)-4-cyclohexyl-L-proline, hydrochloride 10 in part (b), one obtains [1 (S) ,4S]-l.-[N-[.3- (benzoylamino) -2-oxo-4-phenyIbutyl ] -L-alanyl 1-4-cyclohexyl-L-proline, monohydrochloride; ro.p. 139-141* (dec.); [o)g ™ -80* (c = 0.2% in methanol). Rj 0.83 (silica gel; chloroforra/methanol/ 15 acetic acid; 4:1:1)..
Anal, calc'd. for C3iH39H3°s * HC* " 1-54 HjO: C, 62.28; K, 7.26; H, 7.03; Cl, 5.93 Found: C, 62.28: H, 7.01; ft, 7.02;.'C1, 6.16.
Example id 20 (S)i-7- [ (S) -2-t t3- (BenzOylamino) -2-oxo-4-phenylbutyll-amino 1 -1-oxopropy 11 -1.4-dithia-7-a«tspiro(4.41 nonane-8-carboxylle "acid; monohydrochloride Following the procedure of Example 6 . but employing (S) -1,4-dithia-7-azaspiro (4.4] nonane-8-25 carboxylic acid, hydrochloride in part (b) for the L-proline reactant, one obtains (S)-7-[ (S)-2-[ (3-(benzoylamino) - 2,-oxo-4-phehy Ibutyl] amino] -1-oxopropy 1 ] -1, 4-dithia-7.-az aspiro [ 4'. 4 ] nonane- 8-carboxylifc acid', monohydrochloride; a.p. 170-172*; 30 - 36 - (ajp® » -26* (c ™ 1.4% In methanol). 0.78 (silica gel; chloroform/methanol/acetic acid; 6:1:1).
Anal, calc'd. for • HC1 • 0.77H2<>s 5 C, 54.77; H, 5.71; N, 7.10; S, 10.83; Cl, 5.99 Found: C, 54.77} H, 5.70; N, 6.94; S, 10.82; Cl, 6.07.
Example 11 10 f1 IS).5S1-1-[N-13-(Benzoylamino)-2-oxo-4- ohenylbutyll -L-alanyl"1 -4.5-dihydro-3-Phenyl-lH-pyrazole-5-carboxylic" acid, monohydrochloridie Following the procedure of Example 5 but employing (S)-4,5-dihydro-3-phenyl-lH-pyrazole-5-15 carboxylic acid for the L-proline reactant in part (b), one - obtains the above named compound. Example 12 (S)-2-fH-f(SV-3-(Benzoylamino)-2-oxo-4-phenylbUtyl1-' L-alanyl] -1.2.3 f 4-tetrahydro-3-'lsoquinolinecarboxylic 20 acid', monohydrochloride Following the procedure of Example 6 . but employing (S)-l,2,3,4-tetrahydro-3-isoquinoline-carboxylie acid, hydrochloride in part (b) in place of the proline reactant, one obtains (S)-2-(N-[.(S)-25 3- (benzoylamino) -2-oxo-4-phehy Ibutyl] -L-alanyl] -1, 2,3,4-tetrahydro-3.-'i'soquinblinecarboxylic acid, -monohydrochloride.
Example 13 1- [N-[ (S) -3- (Benzoylamino) -2r-oxo-4-phenylbutyll -L-alanyll-2-(2-hydroxyphenyl)-4(R)-thiagolldinecar-boxyllc acid, monohydrochloride Following the procedure of Example 6 but employing 2-[(2-ptienylmethoxy)phenyl]-4(R)-thia-zolidinecarboxylic acid, hydrochloride in part (b) in place of the proline reactant, one obtains after removal of the hydroxy protecting group l-JN-[ (S) -3- (benzoylamino) -2.-OXO-4-phenyIbutyl]-L-alanyl]-2-(2-hydroxyphenyl)-4(R)-thiazolidinfecarboxylic acid, monohydrochloride. - 38 -
Claims (1)
1. CLAIMS I . A compound of the formula £3^ O O R R O II |l I I II R--C-SH-CH-C-CH--M - CH-C-OH , 2 R3 wherein: R is hydrogen, Prot, lower alkyl, cycloalkyl, h H -(ch2)^^^ ' -(.C82)2-»-Prot , -(CH2)3-N-PrOt, -(CH^-N-Prot, -(CHj)2-0-Prot, -(CH2)3-0-Prot, -(CHj)4-0-Prot , -(CH2)a-S-Prot, -(CH2)3-S-Prot, or -(CHjI^-S-Protj - 39 - R^ is hydrogen, lower alkyl, halo substituted lower alkyl, _ _ -(CH2 ]f(Q) ~{CH2)F\0)-0-Prot' • (CH2) ^-^V-O-Prot , -
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39965082A | 1982-07-19 | 1982-07-19 | |
| IE1655/83A IE55818B1 (en) | 1982-07-19 | 1983-07-15 | Pharmaceuticaly active n-acyl dipeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE870109L true IE870109L (en) | 1984-01-19 |
| IE55819B1 IE55819B1 (en) | 1991-01-30 |
Family
ID=26319139
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE109/87A IE55819B1 (en) | 1982-07-19 | 1983-07-15 | Substituted peptide compounds |
| IE110/87A IE55820B1 (en) | 1982-07-19 | 1983-07-15 | Substituted peptide compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE110/87A IE55820B1 (en) | 1982-07-19 | 1983-07-15 | Substituted peptide compounds |
Country Status (1)
| Country | Link |
|---|---|
| IE (2) | IE55819B1 (en) |
-
1983
- 1983-07-15 IE IE109/87A patent/IE55819B1/en not_active IP Right Cessation
- 1983-07-15 IE IE110/87A patent/IE55820B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE55819B1 (en) | 1991-01-30 |
| IE55820B1 (en) | 1991-01-30 |
| IE870110L (en) | 1984-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1258948A (en) | Hydroxy substituted peptide compounds | |
| RU2072359C1 (en) | Acetic acid derivatives or hydrates thereof, or solvates thereof, or pharmaceutically acceptable salts thereof | |
| USH725H (en) | Ureido amino and imino acids, compositions and methods for use | |
| EP1030835B1 (en) | Urea derivatives and their use as integrin inhibitors | |
| EP0618223A2 (en) | Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents | |
| WO1999006436A1 (en) | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| SK158196A3 (en) | Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same | |
| EP0480044A1 (en) | Novel 4h-3,1-benzoxazin-4-one derivative | |
| WO1999006390A1 (en) | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 | |
| BG63876B1 (en) | CELLULAR ADHESION INHIBITORS | |
| US4745124A (en) | Orally effective anti-hypertensive agents | |
| AU599736B2 (en) | Thiol-carboxylic acid derivatives | |
| EP0190891A2 (en) | Novel amino acid derivatives | |
| KR0121793B1 (en) | L-proline derivatives, their preparation and biological applications | |
| WO2002016313A2 (en) | Integrin receptor inhibitors | |
| CA2176414A1 (en) | Acyl guanidine and amidine prodrugs | |
| AU634417B2 (en) | Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses | |
| US5861529A (en) | Farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them | |
| CA1244006A (en) | Substituted peptide compounds | |
| FI89716C (en) | Process for the preparation of therapeutically active proline derivatives | |
| IE870109L (en) | Substituted peptide compounds | |
| CA1295333C (en) | Acylaminoalkanoyl compounds | |
| IE850963L (en) | Amino thiol dipeptides | |
| US5166154A (en) | Imidazo[1,2-a]piperazines | |
| KR890000769B1 (en) | Preparation of Proline Derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |